1. Filgueira CS*, Igo SR, Wang DK, Hirsch M, Schulz DG, Bruckner BA, Grattoni A. Technologies for intrapericardial delivery of therapeutics and cells. Adv. Drug Deliv. Rev. 2019 Feb 21. pii: S0169-409X(19)30022-5. doi: 10.1016/j.addr.2019.02.006.
  2. Di Trani N, Jain P, Chua CYX, Ho JS, Bruno G, Susnjar A, Pons-Faudoa FP, Sizovs A, Hood RL, Smith ZW, Ballerini A, Filgueira CS*, Grattoni A. Nanofluidic microsystem for sustained intraocular delivery of therapeutics. Nanomedicine: nanotechnology, biology, and medicine 2018; Nov 22;16:1-9. doi: 10.1016/j.nano.2018.11.002.
  3. Chua C, Jain P, Ballerini A, Bruno G, Hood RL, Gupte M, Gao S, Di Trani N, Susnjar A, Shelton K, Bushman LR, Folci M, Filgueira CS*, Marzinke MA, Anderson PL, Hu M, Nehete P, Arduino RC, Sastry JK, Grattoni A. Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis. Journal of Controlled Release. 2018; Sept 28; 286, 315-325. doi: 10.1016/j.jconrel.2018.08.010.
  4. Chua C, Jain P, Susnjar A, Rhudy J, Folci M, Ballerini A, Gilbert A, Singh S, Bruno G, Filgueira CS*, Yee C, Butler E, Grattoni A. Nanofluidic drug-eluting seed for sustained intratumoral immunotherapy in triple negative breast cancer. Journal of Controlled Release. 2018 September 10; 285:23-34. doi: 10.1016/j.jconrel.2018.06.035.
  5. Filgueira CS*, Bruno G, Smith ZW, Chua CYX, Ballerini A, Folci M, Gilbert AL, Jain P, Sastry JK, Nehete PN, Shelton KA, Hill LR, Ali A, Youker KA, Grattoni A. Efficacy of sustained delivery of GC-1 from a Nanofluidic system in a spontaneously obese non-human primate: a case study. Biomedical microdevices. 2018; 20(2):49. doi: 10.1007/s10544-018-0296-2.
  6. Bruno G, Di Trani N, Hood RL, Zabre E, Filgueira CS*, Canavese G, Jain P, Smith Z, Demarchi D, Hosali S, Pimpinelli A, Ferrari M, Grattoni A. Unexpected behaviors in molecular transport through size-controlled nanochannels down to the ultra-nanoscale. Nature communications. 2018; 9(1):1682. doi: 10.1038/s41467-018-04133-8.
  7. Filgueira CS*, Ballerini A, Nicolov E, Chua CYX, Jain P, Smith ZW, Gilbert AL, Scaglione F, Grattoni A. A pharmacokinetic study of GC-1 delivery using a nanochannel membrane device. Nanomedicine. 2017; 13(5):1739-1744. doi: 10.1016/j.nano.2017.02.012.
  8. da Silva Teixeira S, Filgueira C*, Sieglaff DH, Benod C, Villagomez R, Minze LJ, Zhang A, Webb P, Nunes MT. 3,5-diiodothyronine (3,5-T2) reduces blood glucose independently of insulin sensitization in obese mice. Acta physiologica. 2017; 220(2):238-250. doi: 10.1111/apha.12821
  9. Kelly AT, Filgueira CS*, Schipper DE, Halas NJ, Whitmire KH. Gold coated iron phosphide core–shell structures RSC Adv. 2017; 7:25848-25854. doi: 10.1039/C7RA01195D
  10. Bruno G, Canavese G, Liu X, Filgueira CS*, Sacco A, Demarchi D, Ferrari M, Grattoni A. The active modulation of drug release by an ionic field effect transistor for an ultra-low power implantable nanofluidic system. Nanoscale. 2016; 8(44):18718-18725. NIHMSID: NIHMS826263. doi: 10.1039/c6nr06235k
  11. Filgueira CS*, Nicolov E, Hood RL, Ballerini A, Garcia-Huidobro J, Lin JZ, Fraga D, Webb P, Sabek OM, Gaber AO, Phillips KJ, Grattoni A. Sustained zero-order delivery of GC-1 from a nanochannel membrane device alleviates metabolic syndrome. International journal of obesity. 2016; 40(11):1776-1783. doi: 10.1038/ijo.2016.129
  12. Sabek OM, Farina M, Fraga DW, Afshar S, Ballerini A, Filgueira CS*, Thekkedath UR, Grattoni A, Gaber AO. Three-dimensional printed polymeric system to encapsulate human mesenchymal stem cells differentiated into islet-like insulin-producing aggregates for diabetes treatment. Journal of tissue engineering. 2016; 7: 2041731416638198. PMID: 27152147, PMCID: PMC4843232. doi: 10.1177/2041731416638198
  13. Ballerini A, Filgueira CS*, Nicolov E, Jain P, Bruno G, Hood RL, Scaglione F, Grattoni A. Sustained Delivery of Tamoxifen from a Nanofluidic Delivery Platform. Drug delivery letters. 2016; 6(2):127-133. doi: 10.2174/2210303106666161129163850
  14. Puhl AC, Milton FA, Cvoro A, Sieglaff DH, Campos JC, Bernardes A, Filgueira CS*, Lindemann JL, Deng T, Neves FA, Polikarpov I, Webb P. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs. Nuclear receptor signaling. 2015; 13:e004. PMID: 26445566, PMCID: PMC4594550; doi: 10.1621/nrs.13004
  15. Milton FA, Cvoro A, Amato AA, Sieglaff DH, Filgueira CS*, Arumanayagam AS, de Lima Mdo C, Pitta IR, de Assis Rocha Neves F, Webb P. PPARγ partial agonist GQ-16 strongly represses a subset of genes in 3T3-L1 adipocytes. Biochemical and biophysical research communications. 2015; 464(3):718-23. PMID: 26168725. doi: 10.1016/j.bbrc.2015.07.011
  16. Filgueira CS*, Benod C, Lou X, Gunamalai PS, Villagomez RA, Strom A, Gustafsson JÅ, Berkenstam AL, Webb P. A screening cascade to identify ERβ ligands. Nuclear receptor signaling. 2014; 12:e003. PMID: 25422593, PMCID: PMC4242290. doi: 10.1621/nrs.12003
  17. Benod C, Villagomez R, Filgueira CS*, Hwang PK, Leonard PG, Poncet-Montange G, Rajagopalan S, Fletterick RJ, Gustafsson JÅ, Webb P. The human orphan nuclear receptor tailless (TLX, NR2E1) is druggable. PloS one. 2014; 9(6):e99440. PMID: 24936658, PMCID: PMC4060991. doi: 10.1371/journal.pone.0099440
  18. Hester B, Campbell GK, López-Mariscal C, Filgueira CL*, Huschka R, Halas NJ, Helmerson K. Tunable optical tweezers for wavelength-dependent measurements. The Review of scientific instruments. 2012; 83(4):043114. PMID: 22559522, PMCID: PMC3350537. doi: 10.1063/1.4704373
  19. Souza G, Stark D, Filgueira C*, Raphael R, Killian T. Culturing Human Primary Lung Cells at the Air-Media Interface with Magnetic Levitation. Biophysical journal. 2011 February 02; 100(3):369a. doi: 10.1016/j.bpj.2010.12.2201
  20. Souza GR, Molina JR, Raphael RM, Ozawa MG, Stark DJ, Levin CS*, Bronk LF, Ananta JS, Mandelin J, Georgescu MM, Bankson JA, Gelovani JG, Killian TC, Arap W, Pasqualini R. Three-dimensional tissue culture based on magnetic cell levitation. Nature nanotechnology. 2010; 5(4):291-6. NIHMSID: NIHMS700773, PMID: 20228788, PMCID: PMC4487889. doi: 10.1038/nnano.2010.23
  21. Kundu J, Levin CS*, Halas NJ. Real-time monitoring of lipid transfer between vesicles and hybrid bilayers on Au nanoshells using surface enhanced Raman scattering (SERS). Nanoscale. 2009; 1(1):114-7. PMID: 20644868. doi: 10.1039/b9nr00063a
  22. Levin CS*, Kundu J, Barhoumi A, Halas NJ. Nanoshell-based substrates for surface enhanced spectroscopic detection of biomolecules. The Analyst. 2009; 134(9):1745-50. PMID: 19684894. doi: 10.1039/b909080k
  23. Levin CS*, Hofmann C, Ali TA, Kelly AT, Morosan E, Nordlander P, Whitmire KH, Halas NJ. Magnetic-plasmonic core-shell nanoparticles. ACS nano. 2009; 3(6):1379-88. NIHMSID: NIHMS117755, PMID: 19441794, PMCID: PMC4108303. doi: 10.1021/nn900118a
  24. Brinson BE, Lassiter JB, Levin CS*, Bardhan R, Mirin N, Halas NJ. Nanoshells made easy: improving Au layer growth on nanoparticle surfaces. Langmuir : the ACS journalof surfaces and colloids. 2008; 24(24):14166-71. NIHMSID: NIHMS91202, PMID: 19360963, PMCID: PMC5922771. doi: 10.1021/la802049p
  25. Levin CS*, Kundu J, Janesko BG, Scuseria GE, Raphael RM, Halas NJ. Interactions of ibuprofen with hybrid lipid bilayers probed by complementary surface-enhanced vibrational spectroscopies. The journal of physical chemistry. B. 2008; 112(45):14168-75. NIHMSID: NIHMS91078, PMID: 18942873, PMCID: PMC4886502. doi: 10.1021/jp804374e
  26. Lal S, Grady NK, Kundu J, Levin CS*, Lassiter JB, Halas NJ. Tailoring plasmonic substrates for surface enhanced spectroscopies. Chemical Society reviews. 2008; 37(5):898-911. PMID: 18443675. doi: 10.1039/b705969h
  27. Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS*, Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP, Bashir R, Halas NJ, Clare SE. A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano letters. 2007; 7(12):3759-65. PMID: 17979310. doi: 10.1021/nl072209h
  28. Ward DR, Grady NK, Levin CS*, Halas NJ, Wu Y, Nordlander P, Natelson D. Electromigrated nanoscale gaps for surface-enhanced Raman spectroscopy. Nano letters. 2007; 7(5):1396-400. PMID: 17430009. doi: 10.1021/nl070625w
View All Publications